News Release For Immediate Release: For More Information, Contact: January 21, 2026 Katie Doyle 336-286-8741 First Bancorp Reports Fourth Quarter and Full Year Results | Fourth Quarter | 2025 | Financial | Data | | | | --- | --- | --- | --- | --- | --- | | (Dollars in 000s, | | | | | | | except per share | | | | | | | data) | Q4-2025 | | Q3-2025 | | Q4-2024 | | Summary Income Statement | | | | | | | Total interest | | | | | | | income | $ 143,634 | | $ 144,200 | | $ 132,395 | | Total interest | | | | | | | ...

Financial Performance - Fourth quarter 2025 net income was $28.8 million, an increase of $18.9 million from the third quarter of 2025, and an increase of $9.7 million from the fourth quarter of 2024[1]. - Adjusted net income for the fourth quarter of 2025 was $30.8 million, up $2.4 million from the third quarter of 2025, and up $10.8 million from the fourth quarter of 2024[2]. - Net income for the year ended December 31, 2025, was $80,310,000, down from $85,264,000 in 2024, a decrease of 5.6%[59]. - Basic earnings per share for Q4 2025 was $0.55, compared to $0.42 in Q4 2024, an increase of 30.9%[59]. - Adjusted net income (non-GAAP) for Q4 2025 was $30,778 million, compared to $19,966 million in Q4 2024, reflecting a growth of 54%[64]. Income and Expenses - Net interest and dividend income was $83.1 million for the fourth quarter of 2025, reflecting a 0.3% increase from the third quarter of 2025 and a 34.9% increase from the fourth quarter of 2024[6]. - Noninterest income decreased by $955,000, or 7.3%, to $12.2 million in the fourth quarter of 2025 compared to the third quarter of 2025[6]. - Noninterest expense was $52.9 million for the fourth quarter of 2025, a decrease of $10.2 million, or 16.2%, from the third quarter of 2025[6]. - Total noninterest expense for Q4 2025 was $52,935 million, compared to $44,322 million in Q4 2024, marking an increase of 19%[63]. Credit and Loans - The provision for credit losses was $3.0 million in the fourth quarter of 2025, down from $19.7 million in the third quarter of 2025[6]. - Nonperforming loans totaled $52.8 million at December 31, 2025, representing 1.0% of total loans, up from 0.8% a year earlier[12]. - Total loans were $5.25 billion at December 31, 2025, a decrease of $12.4 million from September 30, 2025, but an increase of $1.27 billion from December 31, 2024, primarily due to the acquisition of Bancorp Financial[12]. - The allowance for credit losses on loans was $72.301 million as of December 31, 2025, maintaining a ratio of 1.4% to total loans, consistent with September 30, 2025[39][40]. Assets and Equity - Total assets increased to $6,902,675,000 as of December 31, 2025, up from $5,649,377,000 in 2024, representing a growth of 22.2%[57]. - Total stockholders' equity increased to $883,986 million in Q4 2025 from $849,998 million in Q3 2025, a rise of 4.00%[61]. - Retained earnings grew to $526,910 million in Q4 2025, up from $500,075 million in Q3 2025, reflecting an increase of 5.36%[61]. Dividends and Shareholder Returns - The company declared a cash dividend of $0.07 per share, payable on February 9, 2026[6]. - The company declared dividends of $0.25 per share for the year, up from $0.21 in 2024, reflecting a 19% increase[59]. Market and Strategic Position - The company plans to continue strategically buying and selling securities as opportunities arise, reflecting a proactive approach to managing its investment portfolio[12]. - The company recorded a day one purchase accounting credit mark of $17.5 million related to the acquisition in the third quarter of 2025[39]. Future Outlook - The company plans to discuss its fourth quarter 2025 financial results in a conference call scheduled for January 22, 2026[53].

Compensation and Benefits - Executive's base salary during the Transition Period will remain unchanged, and he will be eligible for a bonus under the Company's 2025 bonus plan[6] - Executive will receive a total severance payment of $1,102,500, equivalent to eighteen months of his base salary, paid in equal installments[11] - Executive's annual target bonus for 2026 is set at $918,750, with a prorated amount based on the number of days employed in 2026[12] - The Company will cover COBRA premiums for Executive and eligible dependents for up to eighteen months after the Employment End Date[13] - Executive will vest in 200,891 time-based RSUs if he remains employed through the Planned Transition Date[14] - Two-thirds of any PSUs granted to Executive on April 2, 2025, will remain eligible to vest if they become "Economic ROA Eligible Units"[15] - Executive will serve as a strategic advisor after the Transition Period, receiving a monthly fee of $61,250 until July 3, 2026[8] Transition Agreement - The Transition Agreement allows for an orderly transition of Executive's duties, with a Planned Transition Date set for April 3, 2026[3] - Executive acknowledges that the Transition Agreement will become effective on the date it has been signed by all Parties[32] - The Company agrees to provide the Executive with Severance in consideration of the Executive's execution and non-revocation of the Agreement[43] - Executive represents that the Company and Parent have paid or provided all salary, wages, bonuses, and other benefits due to the Executive[51] - Executive's health insurance benefits shall cease on the Separation Date, with the option to continue under COBRA[52] - The Transition Agreement represents the entire agreement between the Parties concerning the subject matter and supersedes any prior agreements[29] Legal and Arbitration - Any disputes arising out of the terms of the Agreement shall be subject to arbitration under the Federal Arbitration Act[54] - The arbitration must be completed within twelve months of the initial demand for arbitration[55] - The prevailing party in any arbitration is entitled to recover attorneys' fees and costs[67] - The agreement represents the entire understanding between the parties and supersedes all prior agreements[59] - The agreement is governed by the laws of the State of California[68] - The agreement will become effective on the eighth day after the Executive signs it, provided it has not been revoked[69] - The parties agree to waive their right to have any dispute resolved in a court of law[55] Confidentiality and Compliance - Executive agrees to take reasonable precautions to prevent unauthorized use or disclosure of Company trade secrets[7] - Executive certifies the return of all Company and Parent property and information[56] - Any material breach of the agreement allows the Company to recover consideration provided to the Executive[57] - Executive acknowledges that they executed the agreement voluntarily and with understanding of its terms[73] - Executive has no pending or future lawsuits against the Company or any of the Releasees[53] - Executive's resignation from the Board is not due to any disagreement with the Company[7] - The Company will use reasonable best efforts to ensure any successor assumes and agrees to perform the Agreement[35] - The Company will use reasonable best efforts to ensure any successor assumes the agreement[71]

Financial Performance - TrustCo reported a net income of $61.1 million for the year 2025, with a total shareholder return that was three times that of peers[1]. - Q4 2025 net income was $15.6 million, a 38.0% increase from $11.3 million in Q4 2024, with diluted earnings per share rising to $0.85 from $0.59[3]. - Net income for the year ended December 31, 2025, was $61,137, representing a 25.2% increase from $48,833 in 2024[14]. - Basic net income per common share increased to $3.26 in 2025 from $2.57 in 2024, a rise of 26.9%[19]. Interest Income and Margin - For Q4 2025, net interest income increased by 12.4% year-over-year to $43.7 million, driven by asset repricing and effective interest expense management[2]. - The net interest margin for Q4 2025 expanded to 2.82%, up 22 basis points from 2.60% in Q4 2024[3]. - Total interest income rose to $259,416,000 in 2025, compared to $243,316,000 in 2024, marking an increase of 6.6%[18]. - Net interest income after provision for credit losses was $167,373,000, up from $149,939,000, reflecting a growth of 11.6%[18]. Asset and Deposit Growth - Average loans increased by $126.8 million, or 2.5%, in Q4 2025 compared to the same period in 2024, reflecting strong borrower confidence[6]. - Average deposits rose by $208.0 million, or 3.9%, in Q4 2025, primarily due to increases in time deposits and interest-bearing accounts[6]. - Total assets reached $6,440,700,000 as of December 31, 2025, an increase from $6,238,744,000 in 2024, indicating a growth of 3.2%[20]. - Total deposits increased to $5,557,417,000 in 2025, compared to $5,490,314,000 in 2024, showing a growth of 1.2%[20]. Noninterest Income and Expenses - Noninterest income for Q4 2025 was $4,430, slightly up from $4,409 in Q4 2024[12]. - Total noninterest expenses for Q4 2025 decreased to $26,710 from $28,165 in Q4 2024, a reduction of 5.2%[12]. - Noninterest income decreased to $18,945,000 in 2025 from $19,834,000 in 2024, a decline of 4.5%[18]. - Total noninterest expenses slightly decreased to $105,504,000 in 2025 from $105,727,000 in 2024, a reduction of 0.2%[18]. Credit Quality and Provisions - The allowance for credit losses on loans was $52.2 million as of December 31, 2025, with a ratio of 0.99% to total loans, indicating stable asset quality[8]. - Nonperforming loans (NPLs) increased to $20.7 million, or 0.39% of total loans, as of December 31, 2025, reflecting a modest rise in credit risk[8]. - The provision for credit losses for the year ended December 31, 2025, was $1,600, down from $2,000 in 2024[14]. - The coverage ratio improved to 252.5% from 280.8% in the previous quarter, reflecting a decrease in the ability to cover nonperforming loans[23]. Shareholder Equity and Stock Performance - TrustCo repurchased 1 million shares, or 5.3%, of its common stock in 2025, with an additional 2 million shares authorized for repurchase in 2026[7]. - TrustCo's book value per share increased to $38.08 as of December 31, 2025, up 7.1% from $35.56 a year earlier[7]. - The market price per share at the end of Q4 2025 was $41.33, compared to $33.31 at the end of Q4 2024[12]. - Total shareholders' equity as of December 31, 2025, was $686,589,000, a slight decrease from $692,013,000 in 2024[21].

Financial Performance - Net income for the six months ended December 31, 2025, was $19.2 million, a record high, compared to $13.8 million for the same period in 2024, representing a 39.3% increase[2][4] - Pre-provision net income increased by $5.7 million, or 38.7%, to $20.6 million for the six months ended December 31, 2025, compared to $14.9 million for the same period in 2024[7] - Net interest income increased by $9.4 million to $36.6 million for the six months ended December 31, 2025, from $27.2 million for the same period in 2024[8] - Net income for the six months ended December 31, 2025, was $19.2 million, compared to $13.8 million for the same period in 2024, reflecting a significant year-over-year growth[25] - Basic and diluted earnings per share (EPS) increased to $1.13 for the six months ended December 31, 2025, compared to $0.81 for the same period in 2024[25] - Net income (GAAP) for the six months ended December 31, 2025, was $19,162 thousand, an increase of 39.9% from $13,751 thousand in the same period of 2024[33] Asset and Loan Growth - Total assets reached $3.1 billion at December 31, 2025, marking a new record high for the company[4][6] - Total assets increased by $106.4 million, or 3.5%, to $3.1 billion at December 31, 2025, compared to $3.0 billion at June 30, 2025[16] - Net loans amounted to $1.7 billion at December 31, 2025, also a record high for the company[4][6] - Net loans receivable rose by $58.6 million, or 3.6%, to $1.7 billion at December 31, 2025, driven by growth in commercial real estate loans, commercial loans, and home equity loans[18] - Loans receivable increased to $1,687,184 thousand as of December 31, 2025, compared to $1,627,406 thousand at June 30, 2025, reflecting a growth of 3.7%[29] Income and Expense Analysis - Noninterest income decreased by $470,000, or 6.2%, to $7.1 million for the six months ended December 31, 2025, compared to $7.6 million for the same period in 2024[15] - Noninterest expense increased by $1.6 million, or 8.4%, to $20.5 million for the six months ended December 31, 2025, compared to $18.9 million for the same period in 2024[15] - The efficiency ratio improved to 46.93% for the six months ended December 31, 2025, down from 54.39% in the same period of 2024[25] Tax and Equity - The effective tax rate was 10.9% for the six months ended December 31, 2025, compared to 6.9% for the same period in 2024, primarily due to higher pre-tax income[13] - Shareholders' equity increased to $258.3 million at December 31, 2025, primarily due to net income of $19.2 million and a decrease in accumulated other comprehensive loss[18] Recognition and Awards - The company was recognized as a top-performing bank in Piper Sandler's Class of 2025 Bank & Thrift Small-Cap All Stars, ranking 9th out of 24 banks[5] Credit Losses - The allowance for credit losses on loans increased by $1.2 million, or 5.9%, to $21.3 million at December 31, 2025, reflecting an increase in loan volume[18] - The allowance for credit losses on loans was $21,334 thousand as of December 31, 2025, compared to $20,146 thousand at June 30, 2025[29] Deposits - Deposits remained stable at $2.6 billion as of December 31, 2025, with a notable increase in NOW deposits by $48.1 million, or 2.5%[18] - Total deposits reached $2,641,040 thousand as of December 31, 2025, slightly up from $2,639,835 thousand at June 30, 2025[29] Forward-Looking Statements - The Company cautions that forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those anticipated[19] Interest Margin - Net interest margin on a fully taxable-equivalent basis (non-GAAP) improved to 2.83% for the three months ended December 31, 2025, compared to 2.31% in the same period of 2024[31]

Graphic Exhibit 99.1 NEWS - FOR IMMEDIATE RELEASE NYSE American: GORO GOLD RESOURCE CORPORATION ANNOUNCES STRONG PRELIMINARY YEAR-END RESULTS, HIGHLIGHTING OPERATIONAL TURNAROUND Denver, Colorado – January 20, 2026 – Gold Resource Corporation (NYSE American: GORO) (the "Company") is pleased to announce preliminary fourth quarter production results from its Don David Gold Mine that are a significant improvement from previous quarters and represents 45% of the full-year production for 2025. The net result is ...

Financial Performance - Consolidated revenues for the three months ended December 31, 2025, were Rs. 87,268 million, a 4% increase from Rs. 83,586 million in the same period of 2024[227]. - Gross profit for the same period was Rs. 46,806 million, representing 53.6% of revenues, down from Rs. 49,052 million or 58.7% of revenues in the previous year[243]. - Profit before tax for Q4 2025 was Rs. 15,429 million, down from Rs. 18,742 million in Q4 2024[252]. - Profit for the period in Q4 2025 was Rs. 11,896 million, representing 13.6% of total revenues, compared to Rs. 14,038 million and 16.8% in Q4 2024[254]. - Total revenues for the nine months ended December 31, 2025, were Rs. 260,771 million, an 8% increase from Rs. 240,475 million in the same period of 2024[259]. - Net profit for the period was Rs. 40,261 million for the nine months ended December 31, 2025, representing 15.4% of total revenues, down from 17.2% in the same period of 2024[288]. Revenue Breakdown - Revenues from the Global Generics segment increased by 7% to Rs. 79,113 million, driven by growth in Emerging Markets, Europe, and India[229]. - Revenues from North America decreased by 12% to Rs. 29,644 million, attributed to lower sales prices and volumes of existing products[230]. - Revenues from Europe rose by 20% to Rs. 14,476 million, supported by new product launches and increased sales volumes[233]. - Revenues from India increased by 19% to Rs. 16,032 million, largely due to new product launches and higher sales prices[234]. - Revenues from Emerging Markets surged by 32% to Rs. 18,961 million, with 30 new products launched during the period[237]. - Revenues from the Global Generics segment for the nine months ended December 31, 2025, were Rs. 233,231 million, a 9% increase compared to Rs. 214,187 million in 2024[261]. - Revenues from the Global Generics segment in the "Rest of the World" markets increased by 10% to Rs. 16,422 million for the nine months ended December 31, 2025, compared to Rs. 14,903 million for the same period in 2024[274]. - PSAI segment revenues rose by 6% to Rs. 25,649 million for the nine months ended December 31, 2025, compared to Rs. 24,283 million for the same period in 2024[275]. Expenses - Selling, general and administrative expenses increased by 12% to Rs. 26,918 million in Q4 2025, rising as a percentage of total revenues from 28.9% to 30.8%[246]. - Selling, general and administrative expenses increased by 13% to Rs. 79,001 million for the nine months ended December 31, 2025, representing 30.3% of total revenues[279]. - Research and development expenses decreased by 8% to Rs. 6,149 million in Q4 2025, representing 7.0% of total revenues, down from 8.0% in Q4 2024[247][248]. - Research and development expenses decreased by 8% to Rs. 18,595 million for the nine months ended December 31, 2025, representing 7.1% of total revenues[280][281]. Profitability Metrics - The effective tax rate decreased to 22.9% in Q4 2025 from 25.1% in Q4 2024, with tax expense falling to Rs. 3,533 million from Rs. 4,704 million[253]. - Total gross profit was Rs. 143,573 million for the nine months ended December 31, 2025, representing a gross profit margin of 55.1%, down from 59.5% in the same period of 2024[276]. - For the three months ended December 31, 2025, the total gross profit was Rs. 46,806 million, a decrease from Rs. 49,052 million for the same period in 2024, resulting in a gross profit margin decline from 58.7% to 53.6%[244]. - The gross profit margin for the Global Generics segment decreased to 57.4% in Q4 2025 from 61.3% in Q4 2024, primarily due to price erosion and unfavorable product mix changes[244]. Product Launches and Filings - The company filed four new ANDAs with the U.S. FDA during the period, with 73 filings pending approval as of December 31, 2025[232]. - The company launched six new products in North America and ten new generic products in Europe during the three months ended December 31, 2025[231][233]. - The company launched 18 new products in North America and 31 new generic products in Europe during the nine months ended December 31, 2025[265][267]. Cash Flow and Debt - Net cash from operating activities was Rs. 41,110 million for the nine months ended December 31, 2025, compared to Rs. 24,432 million for the same period in 2024[295]. - Principal debt obligations included short-term borrowings of Rs. 50,286 million as of December 31, 2025[291]. - The company reported a net foreign exchange gain of Rs. 1,510 million for the nine months ended December 31, 2025, compared to a loss of Rs. 403 million for the same period in 2024[286]. Corporate Governance - The shares have been transferred by the Promoters to trusts as per SEBI Order dated December 31, 2024[300]. - The report includes a review by an Independent Registered Public Accounting Firm[301]. - The report was signed by Kumar Randhir Singh, Company Secretary of Dr. Reddy's Laboratories Limited[302].

Transaction Summary TrergaanrsdaicntgioNnoOnv-GerAviAewP f•inMaKncSiadlemlievaesrusrfeosu.nRdeaftlieocntaslrteepcohrnteodloagmyosuonlutstioasnsoftoSleepatdeimngbeerd3g0e,s2e0m2i5coansdaudcjtuosrtemdatnourfeafcletucrtin(ig),ae$le1c0tr0omniiclslioandvpoalucnktaagriyndge, batndprseppeacyimaletyntinmdaudsetriianlOapcptolibcearti2o0n2s5•,$a3n,d83(i2i)M3LthTeMDQec3em20b2e5r R20e2v5enaumeo1rt•iz$a1ti,o0n16pMayLmTeMntsQo3f $21002.52Cmreildliiot nAognretehme eUnSt DAdTjeursmtedLEoaBnITBDaAnd2€22.•1MmKilSlioins soene ...

Financial Performance - City Holding Company reported record net income of $130.5 million and diluted earnings of $8.93 per share for the year ended December 31, 2025, achieving a return on assets of 1.97% and a return on tangible equity of 21.2%[2] - Net Income available to common shareholders for the twelve months ended December 31, 2025, was $130,485,000, up from $117,101,000 in 2024, representing a growth of 11.5%[29] - Earnings per share (EPS) for the year ended December 31, 2025, was $8.94, compared to $7.91 in 2024, indicating a year-over-year increase of 13.0%[29] - Net Income Available to Common Shareholders for the three months ended December 31, 2025, was $31,568,000, compared to $28,654,000 for the same period in 2024, representing an increase of 10.3%[33] Income and Revenue - Net interest income increased by $16.1 million, or 7.3%, from $221.1 million in 2024 to $237.2 million in 2025, driven by an increase in average loan balances and a decrease in the cost of interest-bearing liabilities[4] - Non-interest income rose to $77.8 million for the year ended December 31, 2025, compared to $73.3 million in 2024, with a 2.9% increase in core non-interest income[11] - Total Interest Income for the three months ended December 31, 2025, was $81,447,000, an increase from $78,820,000 for the same period in 2024, representing a growth of 2.4%[32] - Net Interest Income for the three months ended December 31, 2025, was $60,825,000, compared to $55,790,000 for the same period in 2024, reflecting an increase of 9.1%[29] Asset and Loan Growth - Total loans increased by $232.2 million, or 5.4%, to $4.51 billion at December 31, 2025, with significant growth in commercial and industrial loans by 8.1%[17] - Total Assets as of December 31, 2025, were $6,722,018,000, an increase from $6,459,459,000 as of December 31, 2024, reflecting a growth of 4.1%[34] - The total gross loans increased to $4,507,005, up from $4,412,775 in the previous quarter, representing a growth of 2.0%[36] - The commercial and industrial loan portfolio grew to $453,975, up from $426,654 in the previous quarter, reflecting a growth of 6.0%[36] Deposits and Liquidity - Period-end deposit balances increased by $156.8 million, or 3.0%, from December 31, 2024, to December 31, 2025, with average depository balances rising by $192.8 million[18] - The Company maintained a gross loan to deposit ratio of 85.0% and a gross loan to asset ratio of 67.0% at December 31, 2025, indicating solid liquidity management[20] - Total Deposits as of December 31, 2025, were $5,300,988,000, compared to $5,144,150,000 as of December 31, 2024, indicating an increase of 3.1%[34] Expenses and Efficiency - Non-interest expenses increased by $6.9 million, or 4.7%, from $147.2 million in 2024 to $154.1 million in 2025, primarily due to salary adjustments and increased health insurance costs[15] - The efficiency ratio for the twelve months ended December 31, 2025, was 48.2%, compared to 48.8% in 2024, indicating improved operational efficiency[30] Capital and Equity - The tangible equity ratio improved from 9.1% at December 31, 2024, to 9.9% at December 31, 2025, reflecting strong capitalization[23] - Stockholders' equity increased to $808,947, compared to $747,143 a year earlier, indicating a strong capital position[39] - The CET I capital ratio at period-end was 16.94%, slightly down from 17.19% in the previous quarter[30] Dividends and Share Repurchase - The Board of Directors approved a quarterly cash dividend of $0.87 per share, payable on January 30, 2026, as part of a share repurchase plan[25] - The company repurchased 141,000 treasury shares at an average price of $119.12 during the three months ended December 31, 2025[30] Credit Quality - The ratio of nonperforming assets to total loans decreased from 0.35% at December 31, 2024, to 0.32% at December 31, 2025, indicating improved credit quality[9] - The allowance for loan losses at the end of the period was $19,862, which is 0.44% of loans outstanding, slightly down from 0.45% in the previous quarter[37] - Total non-performing loans amounted to $13,919, with non-performing assets as a percentage of loans and other real estate owned at 0.32%[38] Market Activity - The average daily trading volume for the three months ended December 31, 2025, was 90,000 shares, compared to 76,000 shares in the previous quarter[30] - New DDA accounts for 2025 totaled 31,427, with a net increase of 3,548 accounts, reflecting a growth rate of 1.4%[48]

Financial Performance - Plumas Bancorp reported Q4 2025 net income of $10.9 million, or $1.58 per share, an increase of 41.56% from $7.7 million, or $1.31 per share in Q4 2024[1]. - For the year ended December 31, 2025, net income was $29.6 million, or $4.60 per share, a slight increase from $28.6 million, or $4.85 per share in 2024[2]. - Net income for 2025 was $29.6 million, a 3.5% increase from $28.6 million in 2024[67]. - Basic earnings per share for the year ended December 31, 2025, was $4.60, a decrease of 5.2% from $4.85 in 2024[71]. - Diluted earnings per share for the year ended December 31, 2025, was $4.54, down from $4.80 in 2024, reflecting a 5.4% decline[71]. Asset and Loan Growth - Gross loans increased by $497 million, or 49%, to $1.5 billion, while total deposits rose by $439 million, or 32%, to $1.8 billion[6]. - Total assets grew by 37.9% from $1.6 billion in 2024 to $2.2 billion in 2025, driven by a 48.8% increase in net loans[64]. - The distribution of total gross loans at December 31, 2025, was $1,512,056 thousand, up from $1,015,424 thousand in 2024[89]. - Commercial real estate loans at December 31, 2025, totaled $1,002,627 thousand, compared to $646,378 thousand in 2024[90]. Equity and Shareholder Value - Shareholder's equity increased by $83 million, or 47%, to $261 million, with book value per share rising by $7.38, or 24%, to $37.52[6]. - Shareholders' equity at the end of 2025 was $261,076 thousand, up from $177,900 thousand in 2024, reflecting a growth of 47%[71]. - Book value per common share increased to $37.52 in 2025 from $30.14 in 2024, a rise of 24.5%[71]. Income and Expenses - Net interest income for the year ended December 31, 2025, was $87.8 million, an increase of $14.1 million from the previous year[43]. - Non-interest income for the year ended December 31, 2025, totaled $10.5 million, an increase of $1.7 million from the previous year[52]. - Total non-interest expense for the year ended December 31, 2025, rose by 22.7% to $51,854 thousand from $42,274 thousand in 2024[87]. - Total non-interest expense increased by $9.6 million from $42.3 million in 2024 to $51.9 million in 2025, with salary and benefit expenses contributing $4.3 million to this increase[53]. Credit Quality and Risk - Nonperforming loans increased to $15.1 million, or 1.0% of total loans, up from $4.1 million, or 0.40% in the previous year[18]. - Provision for credit losses rose significantly by 472.7% from $1.2 million in 2024 to $6.9 million in 2025[67]. - Allowance for credit losses increased to $19,959 thousand in 2025 from $13,196 thousand in 2024, representing a 51.5% increase[71]. - Nonperforming loans as a percentage of total loans rose to 1.00% in 2025 from 0.40% in 2024, indicating a significant increase of 150%[71]. Acquisition Impact - The acquisition of Cornerstone Community Bancorp added $658 million in total assets, including $478 million in gross loans and $580 million in deposits[8]. - Non-recurring expenses related to the acquisition totaled $7.3 million, with non-GAAP net income for 2025 estimated at $35.0 million, resulting in diluted earnings per share of $5.37[9]. - The Company assumed obligations of $12 million in subordinated notes as a result of the merger, including $2 million in 4.75% notes due 2035 and $10 million in 4.75% notes due 2030[24]. - The acquisition of CCB contributed to a $3.0 million increase in salary expenses, impacting overall non-interest expenses[53]. Interest Rates and Margins - The average rate paid on interest-bearing deposits increased from 0.92% in 2024 to 1.43% in 2025[48]. - Net interest margin for the year ended December 31, 2025, increased by 12 basis points to 4.91%[49]. - Interest expense increased by $3.2 million to $13.9 million for the year ended December 31, 2025, primarily due to the acquisition of Cornerstone[47]. Liquidity Management - The Company managed liquidity through competitive deposit rates and established lines of credit, with the ability to borrow up to $400 million from the FHLB[30].